Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
A revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and Drug Administration. However, some experts are concerned about the high price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results